Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension

G de Simone1, R B Devereux, M J Koren

  • 1Department of Medicine, New York Hospital-Cornell Medical Center, New York 10021, USA.

Circulation
|January 15, 1996
PubMed

Insights

Depressed midwall shortening in asymptomatic hypertensive patients predicts adverse cardiovascular events. Combining this with higher left ventricular mass identifies individuals at significantly increased risk.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Echocardiography

Background:

  • A significant number of asymptomatic hypertensive patients exhibit reduced left ventricular (LV) performance, detectable by midwall shortening/end-systolic stress but not endocardial shortening measures.
  • The prognostic significance of this depressed midwall ventricular performance in hypertension remains unclear.

Purpose of the Study:

  • To investigate whether depressed midwall shortening in hypertensive patients has prognostic implications for cardiovascular events.
  • To determine if midwall shortening, in conjunction with LV mass, can identify high-risk individuals.

Main Methods:

  • Analysis of echocardiographic endocardial and midwall LV fractional shortening/circumferential end-systolic stress relations in 294 hypertensive patients.
  • Assessment of cardiovascular morbid events over a mean 10-year follow-up.
  • Logistic and survival analyses to identify independent predictors of cardiovascular events and cardiac death.

Main Results:

  • Patients with lower midwall shortening (absolute or predicted) were more prone to cardiovascular events (P < .004).
  • A markedly increased risk of cardiovascular events (29%) and death (10%) was observed in patients with high LV mass index and low midwall shortening.
  • Low midwall shortening, high LV mass, increasing age, and high systolic blood pressure independently predicted cardiovascular events. Low midwall shortening also predicted cardiac death, particularly in patients with LV hypertrophy.

Conclusions:

  • Depressed midwall shortening serves as a significant predictor of adverse outcomes in arterial hypertension.
  • The combination of increased left ventricular mass and reduced midwall shortening identifies hypertensive individuals at substantially elevated cardiovascular risk.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...